Lumiracoxib 400 mg har i kliniske forsøg lindret smerte i akutte analgetiske modeller af post- operative tandsmerter, post- operative ortopædiske smerter og primær dysmenorré.
In clinical studies, lumiracoxib 400 mg relieved pain in acute analgesic models of post-operative dental pain, post-orthopaedic surgical pain, and primary dysmenorrhea.